About Us
Who We Are
Antelope Surgical Solutions, Inc. is a pre-revenue, early-stage radiopharmaceutical company based in NYC, focused on the research and development of novel small molecule drugs for radioligand-targeted therapy, PET imaging, and fluorescence-guided surgery in the treatment of various cancers.
Amy Wu, MD, Founder and CEO
Dr. Amy Wu is a board-certified, fellowship-trained otolaryngologist-head and neck surgeon in New York, NY. From her undergraduate studies in chemistry and physics at the University of Pennsylvania to medical school at Stanford University and surgical residency at UC San Diego Medical Center, she has been actively engaged in research throughout her career. Dr. Wu has published alongside Nobel laureate Dr. Roger Tsien and continues to collaborate with scientists to develop innovative diagnostic and therapeutic agents for clinical applications. Discover more about Dr. Wu and explore her publications through the links below.
Richard Ting, PhD, Chief Quality and Science Officer
Dr. Richard Ting is a distinguished scientist who earned his undergraduate and graduate degrees from the University of British Columbia in Vancouver, Canada, where he also trained at the TRIUMF particle accelerator center. He completed postdoctoral studies under Nobel laureate Dr. Roger Tsien at the University of California, San Diego, where he began his collaboration with Dr. Amy Wu. Dr. Ting later led a successful academic chemistry lab in NYC and has published extensively with global collaborators. His expertise includes radiochemistry, fluorescent chemistry, GMP manufacturing, artificial intelligence, optics, and computer programming.